Nuclear Medicine Communications

Nuclear Medicine Communications

核医学通讯

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Nuclear Medicine Communications》是由Lippincott Williams and Wilkins Ltd.出版社于1980年创办的英文国际期刊(ISSN: 0143-3636,E-ISSN: 1473-5628),该期刊长期致力于核医学领域的创新研究,主要研究方向为医学-核医学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0599...%),以发表核医学领域等方向的原创性研究为核心(研究类文章占比89.86%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在138篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Nuclear Medicine Communications审稿周期约为 一般,3-8周 。该刊近年未被列入国际预警名单,年发文量约138篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 138 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 138 / 204

32.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q3 139 / 204

32.11%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:2.2 SJR:0.374 SNIP:0.419
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q3 206 / 333

38%

期刊发文

  • Value of Tc-99m-MIBI SPECT/CT in the localization of recurrent lesions in patients with suspected recurrent parathyroid carcinoma

    Author: Guo, Yue-Hong; Huang, Jing-Wei; Wang, Ying; Lu, Ruigang; Yang, Min-Fu

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 1, pp. 18-26. DOI: 10.1097/MNM.0000000000001641

  • A retrospective study of clinical features and prognosis of patients with Graves' disease and ophthalmopathy

    Author: Rui, Zhong Ying; Yin, Xue; Wang, Xuan; Shen, Jie; Zheng, Wei

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 2, pp. 137-141. DOI: 10.1097/MNM.0000000000001649

  • A novel urokinase plasminogen activator receptor-targeted peptide-based probe for in-vivo molecular imaging of glioblastoma

    Author: Han, Yunfeng; Tu, Le; Zhang, Yongxue; Xu, Liying; Sun, Ziyan

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 2, pp. 142-149. DOI: 10.1097/MNM.0000000000001644

  • Utility of pre-treatment F-18-fluorodeoxyglucose PET radiomic analysis in assessing nodal involvement in cervical cancer

    Author: Chan, Kit Chi; Perucho, Jose A. U.; Subramaniam, Rathan M.; Lee, Elaine Y. P.

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 5, pp. 375-380. DOI: 10.1097/MNM.0000000000001672

  • Comparison of Ga-68-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies

    Author: Zheng, Wenlu; Liu, Lin; Feng, Yue; Wang, Li; Chen, Yue

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 3, pp. 194-203. DOI: 10.1097/MNM.0000000000001653

  • Correlations between glucose metabolism of bone marrow on F-18-fluoro-D-glucose PET/computed tomography and hematopoietic cell populations in autoimmune diseases

    Author: Zhang, Tong; Zhang, Jifeng; Wang, Hongjia; Li, Ping

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 3, pp. 212-218. DOI: 10.1097/MNM.0000000000001657

  • Using eZIS of SPECT to evaluate the therapeutic effect of carotid endarterectomy

    Author: Zhang, Zhiting; Sun, Danyang; Wang, Xuan; Li, Wei

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 4, pp. 252-258. DOI: 10.1097/MNM.0000000000001662

  • Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma

    Author: Pu, Yongzhu; Wang, Chun; Xie, Ran; Zhao, Sheng; Li, Kun; Yang, Conghui; Li, Jindan; Xiang, Anshi; Wang, Yasong; Chen, Long; Sun, Hua

    Journal: NUCLEAR MEDICINE COMMUNICATIONS. 2023; Vol. 44, Issue 4, pp. 318-329. DOI: 10.1097/MNM.0000000000001668